Interaction between placental alkaline phosphatase and ABO system polymorphisms. Effects on the clinical manifestations of feto-maternal ABO incompatibility.
D000017:ABO Blood-Group System; D000328:Adult; D000469:Alkaline Phosphatase / Q000032:analysis* / Q000097:blood; D001663:Bilirubin / Q000097:blood; D044383:Black People; D001787:Blood Group Incompatibility; D003298:Coombs Test; D005260:Female; D005331:Fetomaternal Transfusion; D006801:Humans; D007114:Immunization; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000175:diagnosis; D010641:Phenotype; D010920:Placenta / Q000201:enzymology*; D011110:Polymorphism, Genetic; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D044465:White People
D000017:ABO Blood-Group System; D012204:Rh-Hr Blood-Group System; D000469:Alkaline Phosphatase; D001663:Bilirubin